CHINA PHARMA HOLDINGS INC (CPHI)

US16941T3023 - Common Stock

0.1723  0 (-0.98%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
9.642M
-11.26%		8.104M
-15.95%		7.011M
-13.49%
EBITDA
YoY % growth
227K
124.75%		-848K
-473.57%		2K
100.24%
EBIT
YoY % growth
-2.861M
-10.98%		-3.549M
-24.05%		-2.752M
22.46%
Operating Margin
-29.67%-43.79%-39.25%
EPS
YoY % growth
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 924.94K
-15.76%		%
Q1 2024
Q2Q % growth		 1.37M
-30.10%		%
Q4 2023
Q2Q % growth		 2.15M
-26.40%		%
Q3 2023
Q2Q % growth		 1.803M
-8.29%		%
Q2 2023
Q2Q % growth		 1.098M
-31.93%		%
Q1 2023
Q2Q % growth		 1.96M
22.19%		%
Q4 2022
Q2Q % growth		 2.921M
1.11%		%
Q3 2022
Q2Q % growth		 1.966M
-0.66%		%
Q2 2022
Q2Q % growth		 1.613M
-33.24%		%
Q1 2022
Q2Q % growth		 1.604M
-31.98%		%
Q4 2021
Q2Q % growth		 2.889M
-1.43%		%
Q3 2021
Q2Q % growth		 1.979M
-17.58%		%
Q2 2021
Q2Q % growth		 2.416M
-35.93%		%
Q1 2021
Q2Q % growth		 2.358M
33.67%		%
Q4 2020
Q2Q % growth		 2.931M
-3.84%		%
Q3 2020
Q2Q % growth		 2.401M
1.01%		%
Q2 2020
Q2Q % growth		 3.771M
46.79%		%
Q1 2020
Q2Q % growth		 1.764M
-39.77%		%
Q4 2019
Q2Q % growth		 3.048M
-6.01%		%
Q3 2019
Q2Q % growth		 2.377M
3.44%		%
Q2 2019
Q2Q % growth		 2.569M
-19.06%		%
Q1 2019
Q2Q % growth		 2.929M
-19.00%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A